<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32938739</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Retrospective Review of Clinical Utility of Shotgun Metagenomic Sequencing Testing of Cerebrospinal Fluid from a U.S. Tertiary Care Medical Center.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e01729-20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.01729-20</ELocationID><Abstract><AbstractText>Shotgun metagenomic sequencing can detect nucleic acids from bacteria, fungi, viruses, and/or parasites in clinical specimens; however, little data exist to guide its optimal application to clinical practice. We retrospectively reviewed results of shotgun metagenomic sequencing testing requested on cerebrospinal fluid samples submitted to an outside reference laboratory from December 2017 through December 2019. Of the 53 samples from Mayo Clinic patients, 47 were requested by neurologists, with infectious diseases consultation in 23 cases. The majority of patients presented with difficult-to-diagnose subacute or chronic conditions. Positive results were reported for 9 (17%) Mayo Clinic patient samples, with 6 interpreted as likely contamination. Potential pathogens reported included bunyavirus, human herpesvirus 7, and enterovirus D-68, ultimately impacting care in two cases. Twenty-seven additional samples were submitted from Mayo Clinic Laboratories reference clients, with positive results reported for three (11%): two with potential pathogens (West Nile virus and <i>Toxoplasma gondii</i>) and one with <i>Streptococcus</i> species with other bacteria below the reporting threshold (considered to represent contamination). Of 68 negative results, 10 included comments on decreased sensitivity due to high DNA background (<i>n</i>&#x2009;=&#x2009;5), high RNA background (<i>n</i>&#x2009;=&#x2009;1), insufficient RNA read depth (<i>n</i>&#x2009;=&#x2009;3), or quality control (QC) failure with an external RNA control (<i>n</i>&#x2009;=&#x2009;1). The overall positive-result rate was 15% (12/80), with 58% (7/12) of these interpreted as being inconsistent with the patient's clinical presentation. Overall, potential pathogens were found in a low percentage of cases, and positive results were often of unclear clinical significance. Testing was commonly employed in cases of diagnostic uncertainty and when immunotherapy was being considered.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodino</LastName><ForeName>Kyle G</ForeName><Initials>KG</Initials><Identifier Source="ORCID">0000-0001-9308-4810</Identifier><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledano</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norgan</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pritt</LastName><ForeName>Bobbi S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binnicker</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-2537-7165</Identifier><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Joseph D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aksamit</LastName><ForeName>Allen J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Robin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6344-4141</Identifier><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA patel.robin@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="Y">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054892" MajorTopicYN="N">Metagenome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056186" MajorTopicYN="Y">Metagenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063128" MajorTopicYN="N">Tertiary Healthcare</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">metagenomics</Keyword><Keyword MajorTopicYN="N">next-generation sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32938739</ArticleId><ArticleId IdType="pmc">PMC7685881</ArticleId><ArticleId IdType="doi">10.1128/JCM.01729-20</ArticleId><ArticleId IdType="pii">JCM.01729-20</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khetsuriani N, Holman RC, Anderson LJ. 2002. Burden of encephalitis-associated hospitalizations in the United States, 1988&#x2013;1997. Clin Infect Dis 35:175&#x2013;182. doi:10.1086/341301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/341301</ArticleId><ArticleId IdType="pubmed">12087524</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ, California Encephalitis Project, 1998-2000. 2003. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 36:731&#x2013;742. doi:10.1086/367841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/367841</ArticleId><ArticleId IdType="pubmed">12627357</ArticleId></ArticleIdList></Reference><Reference><Citation>Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS, UK Health Protection Agency Aetiology of Encephalitis Study Group. 2010. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835&#x2013;844. doi:10.1016/S1473-3099(10)70222-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70222-X</ArticleId><ArticleId IdType="pubmed">20952256</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh TD, Fugate JE, Rabinstein AA. 2015. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology 84:359&#x2013;366. doi:10.1212/WNL.0000000000001190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001190</ArticleId><ArticleId IdType="pubmed">25540320</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M, Weng X, Chen L, Chen Y, Chi Y, Chen W, Hu Z. 2020. Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report. BMC Infect Dis 20:159. doi:10.1186/s12879-020-4872-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4872-8</ArticleId><ArticleId IdType="pmc">PMC7031966</ArticleId><ArticleId IdType="pubmed">32075599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao LY, Xu GR, Dai TJ. 2020. Precision diagnosis and therapy of a case of brain abscesses associated with asymptomatic pulmonary arteriovenous fistulas. BMC Infect Dis 20:370. doi:10.1186/s12879-020-05092-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05092-6</ArticleId><ArticleId IdType="pmc">PMC7247166</ArticleId><ArticleId IdType="pubmed">32448130</ArticleId></ArticleIdList></Reference><Reference><Citation>Simner PJ, Miller S, Carroll KC. 2018. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis 66:778&#x2013;788. doi:10.1093/cid/cix881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix881</ArticleId><ArticleId IdType="pmc">PMC7108102</ArticleId><ArticleId IdType="pubmed">29040428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, Salamat SM, Somasekar S, Federman S, Miller S, Sokolic R, Garabedian E, Candotti F, Buckley RH, Reed KD, Meyer TL, Seroogy CM, Galloway R, Henderson SL, Gern JE, DeRisi JL, Chiu CY. 2014. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:2408&#x2013;2417. doi:10.1056/NEJMoa1401268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401268</ArticleId><ArticleId IdType="pmc">PMC4134948</ArticleId><ArticleId IdType="pubmed">24896819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Shanbhag NM, Reid MJ, Singhal NS, Gelfand JM, Sample HA, Benkli B, O&#x2019;Donovan BD, Ali IK, Keating MK, Dunnebacke TH, Wood MD, Bollen A, DeRisi JL. 2015. Diagnosing Balamuthia mandrillaris encephalitis with metagenomic deep sequencing. Ann Neurol 78:722&#x2013;730. doi:10.1002/ana.24499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24499</ArticleId><ArticleId IdType="pmc">PMC4624031</ArticleId><ArticleId IdType="pubmed">26290222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Zimmermann LL, Crawford ED, Sample HA, Soni PR, Baker AN, Khan LM, DeRisi JL. 2017. Acute West Nile virus meningoencephalitis diagnosed via metagenomic deep sequencing of cerebrospinal fluid in a renal transplant patient. Am J Transplant 17:803&#x2013;808. doi:10.1111/ajt.14058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.14058</ArticleId><ArticleId IdType="pmc">PMC5347949</ArticleId><ArticleId IdType="pubmed">27647685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Suan D, Duggins A, Schubert RD, Khan LM, Sample HA, Zorn KC, Rodrigues Hoffman A, Blick A, Shingde M, DeRisi JL. 2017. A novel cause of chronic viral meningoencephalitis: Cache Valley virus. Ann Neurol 82:105&#x2013;114. doi:10.1002/ana.24982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24982</ArticleId><ArticleId IdType="pmc">PMC5546801</ArticleId><ArticleId IdType="pubmed">28628941</ArticleId></ArticleIdList></Reference><Reference><Citation>Murkey JA, Chew KW, Carlson M, Shannon CL, Sirohi D, Sample HA, Wilson MR, Vespa P, Humphries RM, Miller S, Klausner JD, Chiu CY. 2017. Hepatitis E virus-associated meningoencephalitis in a lung transplant recipient diagnosed by clinical metagenomic sequencing. Open Forum Infect Dis 4:ofx121. doi:10.1093/ofid/ofx121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofx121</ArticleId><ArticleId IdType="pmc">PMC5508774</ArticleId><ArticleId IdType="pubmed">28721353</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongkolrattanothai K, Naccache SN, Bender JM, Samayoa E, Pham E, Yu G, Dien Bard J, Miller S, Aldrovandi G, Chiu CY. 2017. Neurobrucellosis: unexpected answer from metagenomic next-generation sequencing. J Pediatr Infect Dis Soc 6:393&#x2013;398. doi:10.1093/jpids/piw066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piw066</ArticleId><ArticleId IdType="pmc">PMC6251619</ArticleId><ArticleId IdType="pubmed">28062553</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CY, Coffey LL, Murkey J, Symmes K, Sample HA, Wilson MR, Naccache SN, Arevalo S, Somasekar S, Federman S, Stryke D, Vespa P, Schiller G, Messenger S, Humphries R, Miller S, Klausner JD. 2017. Diagnosis of fatal human case of St. Louis encephalitis virus infection by metagenomic sequencing, California, 2016. Emerg Infect Dis 23:1964&#x2013;1968. doi:10.3201/eid2310.161986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2310.161986</ArticleId><ArticleId IdType="pmc">PMC5621550</ArticleId><ArticleId IdType="pubmed">28930022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY. 2019. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 380:2327&#x2013;2340. doi:10.1056/NEJMoa1803396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1803396</ArticleId><ArticleId IdType="pmc">PMC6764751</ArticleId><ArticleId IdType="pubmed">31189036</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S, Naccache SN, Samayoa E, Messacar K, Arevalo S, Federman S, Stryke D, Pham E, Fung B, Bolosky WJ, Ingebrigtsen D, Lorizio W, Paff SM, Leake JA, Pesano R, DeBiasi R, Dominguez S, Chiu CY. 2019. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res 29:831&#x2013;842. doi:10.1101/gr.238170.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.238170.118</ArticleId><ArticleId IdType="pmc">PMC6499319</ArticleId><ArticleId IdType="pubmed">30992304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossoff J, Chaudhury S, Soneji M, Patel SJ, Kwon S, Armstrong A, Muller WJ. 2019. Noninvasive diagnosis of infection using plasma next-generation sequencing: a single-center experience. Open Forum Infect Dis 6:ofz327. doi:10.1093/ofid/ofz327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz327</ArticleId><ArticleId IdType="pmc">PMC6677669</ArticleId><ArticleId IdType="pubmed">31375834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran PS, Wilson MR. 13 July 2020. Metagenomics for neurological infections&#x2014;expanding our imagination. Nat Rev Neurol doi:10.1038/s41582-020-0374-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0374-y</ArticleId><ArticleId IdType="pmc">PMC7356134</ArticleId><ArticleId IdType="pubmed">32661342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>